Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2

Virology Journal

Volumn 10, Issue , 2013, Pages

  Li, Xiaojun ^a   Fan, Peihun ^a   Jin, Jun ^a   Su, Weiheng ^a   An, Dong ^a   Xu, Lin ^a   Sun, Shiyang ^a   Zhang, Yan ^a   Meng, Xiangyu ^a   Gao, Feng ^a,b   Kong, Wei ^a   Jiang, Chunlai ^a  

^a JILIN UNIVERSITY   (China)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

293 cells; EV71 CA16; RD cells; SCARB2; Vero cells

Indexed keywords

LENTIVIRUS VECTOR; MESSENGER RNA; SCAVENGER RECEPTOR B; SCAVENGER RECEPTOR B2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS; COXSACKIEVIRUS A GROUP TYPE 16; ENTEROVIRUS; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN ENTEROVIRUS TYPE 71; IMMUNOFLUORESCENCE; KIDNEY CELL; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE EXPRESSION; VERO CELL; VIRUS REPLICATION; VIRUS TITRATION;

CERCOPITHECUS AETHIOPS; COXSACKIEVIRUS; ENTEROVIRUS; HUMAN ENTEROVIRUS 71; LENTIVIRUS; PICORNAVIRIDAE; SOLEIDAE;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; ENTEROVIRUS; ENTEROVIRUS A, HUMAN; GENE EXPRESSION; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; RECEPTORS, SCAVENGER; RECEPTORS, VIRUS; TRANSDUCTION, GENETIC; VIRUS CULTIVATION;

EID: 84881032951     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-250     Document Type: Article

References (39)

1. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. Oberste MS, Maher K, Kilpatrick DR, Pallansch MA, J Virol 1999 73 1941 1948 9971773 (Pubitemid 29098095)
2. An overview of the evolution of enterovirus 71 and its clinical and public health significance. McMinn PC, FEMS Microbiol Rev 2002 26 91 107 10.1111/j.1574-6976.2002.tb00601.x 12007645 (Pubitemid 34454778)
3. Enterovirus 71 infection: a new threat to global public health? Qiu J, Lancet Neurol 2008 7 868 869 10.1016/S1474-4422(08)70207-2 18848307
4. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, Totsuka A, Nishio O, Microbiol Immunol 2002 46 621 627 12437029
5. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, Ho KK, Han LL, Pallansch MA, Suleiman AB, et al. Clin Infect Dis 2000 31 678 683 10.1086/314032 11017815 (Pubitemid 32295486)
6. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR, N Engl J Med 1999 341 929 935 10.1056/NEJM199909233411301 10498487 (Pubitemid 29441546)
7. Hand, foot, and mouth disease outbreak reported in Singapore. Ahmad K, Lancet 2000 356 1338 11073035
8. Identification of Bulgarian strain 258 of enterovirus 71. Melnick JL, Schmidt NJ, Mirkovic RR, Chumakov MP, Lavrova IK, Voroshilova MK, Intervirology 1980 12 297 302 6244233 (Pubitemid 10169192)
9. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Perez-Velez CM, Anderson MS, Robinson CC, McFarland EJ, Nix WA, Pallansch MA, Oberste MS, Glode MP, Clin Infect Dis 2007 45 950 957 10.1086/521895 17879907 (Pubitemid 47580341)
10. EV71: an emerging infectious disease vaccine target in the Far East? Xu J, Qian Y, Wang S, Serrano JM, Li W, Huang Z, Lu S, Vaccine 2010 28 3516 3521 10.1016/j.vaccine.2010.03.003 20304038
11. Clinical features, diagnosis, and management of enterovirus 71. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T, Lancet Neurol 2010 9 1097 1105 10.1016/S1474-4422(10)70209-X 20965438
12. Human rhabdomyosarcoma cells for rapid detection of enteroviruses by shell-vial assay. Perez-Ruiz M, Navarro-Mari JM, Palacios del Valle E, Rosa-Fraile M, J Med Microbiol 2003 52 789 791 10.1099/jmm.0.05237-0 12909656 (Pubitemid 37174782)
13. Enterovirus infections: diagnosis and treatment. Sawyer MH, Pediatr Infect Dis J 1999 18 1033 1039 quiz 1040 10.1097/00006454-199912000-00002 10608620
14. Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Liu CC, Chou AH, Lien SP, Lin HY, Liu SJ, Chang JY, Guo MS, Chow YH, Yang WS, Chang KH, et al. Vaccine 2011 29 4362 4372 10.1016/j.vaccine.2011. 04.010 21501643
15. Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity. Chen Y, Li C, He D, Cheng T, Ge S, Shih JW, Zhao Q, Chen PJ, Zhang J, Xia N, Vaccine 2013 31 425 430 10.1016/j.vaccine.2012.10. 032 23088887
16. Diagnosis of hand, foot, and mouth disease caused by EV71 and other enteroviruses by a one-step, single tube, duplex RT-PCR. Jiang B, Zhang J, You X, Dong C, Cheng X, Dai X, Meng J, J Med Virol 2012 84 1803 1808 10.1002/jmv.23391 22997084
17. A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine. Cheng A, Fung CP, Liu CC, Lin YT, Tsai HY, Chang SC, Chou AH, Chang JY, Jiang RH, Hsieh YC, et al. Vaccine 2013 31 2471 2476 10.1016/j.vaccine.2013.03.015 23541623
18. Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates. Chou AH, Liu CC, Chang CP, Guo MS, Hsieh SY, Yang WH, Chao HJ, Wu CL, Huang JL, Lee MS, et al. PLoS One 2012 7 34834 10.1371/journal.pone. 0034834 22529942
19. Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Lin YC, Wu CN, Shih SR, Ho MS, Vaccine 2002 20 2485 2493 10.1016/S0264-410X(02)00182-2 12057603 (Pubitemid 34615586)
20. [Evaluation of immune responses and related patho-inflammatory reactions of a candidate inactivated EV71 vaccine in neonatal monkeys]. Zhang XM, Zhao HL, Wang JJ, Liao Y, Na RX, Wang LC, Liu LD, Gao JH, Tang DH, Wang CZ, Li QH, Zhonghua Yi Xue Za Zhi 2011 91 1977 1981 22093894
21. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H, Nat Med 2009 15 794 797 10.1038/nm.1961 19543284
22. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S, Nat Med 2009 15 798 801 10.1038/nm.1992 19543282
23. At the acidic edge: emerging functions for lysosomal membrane proteins. Eskelinen EL, Tanaka Y, Saftig P, Trends Cell Biol 2003 13 137 145 10.1016/S0962-8924(03)00005-9 12628346 (Pubitemid 36293786)
24. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. Kuronita T, Eskelinen EL, Fujita H, Saftig P, Himeno M, Tanaka Y, J Cell Sci 2002 115 4117 4131 10.1242/jcs.00075 12356916 (Pubitemid 35446808)
25. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. Yamayoshi S, Ohka S, Fujii K, Koike S, J Virol 2013 87 3335 3347 10.1128/JVI.02070-12 23302872
26. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, Nishimura H, Sanjoh K, Katsushima N, Itagaki T, et al. J Virol 2012 86 5686 5696 10.1128/JVI.00020-12 22438546
27. Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases. Yamayoshi S, Fujii K, Koike S, Front Microbiol 2012 3 32 22363322
28. A convenient rapid culture assay for the detection of enteroviruses in clinical samples: comparison with conventional cell culture and RT-PCR. Terletskaia-Ladwig E, Meier S, Hahn R, Leinmuller M, Schneider F, Enders M, J Med Microbiol 2008 57 1000 1006 10.1099/jmm.0.47799-0 18628502
29. Comparison of a rapid culture method combining an immunoperoxidase test and a group specific anti-VP1 monoclonal antibody with conventional virus isolation techniques for routine detection of enteroviruses in stools. Bourlet T, Gharbi J, Omar S, Aouni M, Pozzetto B, J Med Virol 1998 54 204 209 10.1002/(SICI)1096-9071(199803)54:3<204::AID-JMV11>3.0.CO;2-H 9515770 (Pubitemid 28102812)
30. Comparison of rhabdomyosarcoma, buffalo green monkey kidney epithelial, A549 (human lung epithelial) cells and human embryonic lung fibroblasts for isolation of enteroviruses from clinical samples. Kok TW, Pryor T, Payne L, J Clin Virol 1998 11 61 65 10.1016/S0928-0197(98)00026-9 9784144 (Pubitemid 28462074)
31. Comparison of mixed cell culture containing genetically engineered BGMK and CaCo-2 cells (Super E-Mix) with RT-PCR and conventional cell culture for the diagnosis of enterovirus meningitis. Buck GE, Wiesemann M, Stewart L, J Clin Virol 2002 25 Suppl 1 13 S18 12467773
32. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. Chen P, Song Z, Qi Y, Feng X, Xu N, Sun Y, Wu X, Yao X, Mao Q, Li X, et al. J Biol Chem 2012 287 6406 6420 10.1074/jbc.M111.301622 22219187
33. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Barrett PN, Mundt W, Kistner O, Howard MK, Expert Rev Vaccines 2009 8 607 618 10.1586/erv.09.19 19397417
34. Efficient transgenesis in farm animals by lentiviral vectors. Hofmann A, Kessler B, Ewerling S, Weppert M, Vogg B, Ludwig H, Stojkovic M, Boelhauve M, Brem G, Wolf E, Pfeifer A, EMBO Rep 2003 4 1054 1060 10.1038/sj.embor.7400007 14566324 (Pubitemid 37527423)
35. Certain promise and uncertain peril. The debate on xenotransplantation. Weiss RA, EMBO Rep 2000 1 2 4 10.1093/embo-reports/kvd017 11256618
36. Efficient production of germline transgenic chickens using lentiviral vectors. McGrew MJ, Sherman A, Ellard FM, Lillico SG, Gilhooley HJ, Kingsman AJ, Mitrophanous KA, Sang H, EMBO Rep 2004 5 728 733 10.1038/sj.embor.7400171 15192698 (Pubitemid 39173010)
37. Lentiviral transgenesis. Pfeifer A, Transgenic Res 2004 13 513 522 10.1007/s11248-004-2735-5 15672832 (Pubitemid 39622938)
38. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications. Farley DC, Iqball S, Smith JC, Miskin JE, Kingsman SM, Mitrophanous KA, J Gene Med 2007 9 345 356 10.1002/jgm.1022 17366519 (Pubitemid 46796580)
39. Replication kinetics of coxsackievirus A16 in human rhabdomyosarcoma cells. Jin J, Han M, Xu L, An D, Kong W, Jiang C, Virol Sin 2012 27 221 227 10.1007/s12250-012-3245-x 22899429